EcoDrugPlus

Janus Kinase 1

Ensembl ID : ENSAOCG00000005676
Gene Symbol: JAK1
3 Cross references
214 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSAOCG00000017428
Gene Symbol: KRAS
3 Cross references
208 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSAOCG00000018977
Gene Symbol: MALT1
3 Cross references
198 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSAOCG00000000665
Gene Symbol: MAPKAPK2
4 Cross references
186 Possible Orthologues:

Mapk Activated Protein Kinase 2b

Ensembl ID : ENSAOCG00000017822
Gene Symbol: MAPKAPK2B
1 Cross references
174 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSAOCG00000016043
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSAOCG00000000062
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSAOCG00000017600
Gene Symbol: MET
3 Cross references
204 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSAOCG00000018989
Gene Symbol: MLST8
3 Cross references
195 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSAOCG00000012184
Gene Symbol: LOC111569366
3 Cross references
180 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSAOCG00000001580
Gene Symbol: NOX4
4 Cross references
150 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSAOCG00000018860
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).